Blogs and News

The increasingly popular Functional Service Provider (FSP) model in clinical research can offer sponsors like biotech and pharma companies flexibility at a lower cost compared to full-service. But what does this mean for compliance? And how can you use FSP to boost quality? We address these questions in this blog post.

Clinical trials are complex, which means they involve a lot of work and require a range of skills and experience. It can be daunting when you start planning a clinical trial – how will you manage everything that’s needed, especially if you have a small team?

Medical devices are vital for diagnosing, treating and monitoring diseases, saving lives and keeping us alive. There are about 2 million medical devices on the market today, in more than 7,000 categories. Each of them underwent a journey from innovation through clinical trials to the market. Here we look at medical devices, the challenges you can face with a trial and how to overcome them.

Cardiovascular clinical trials are essential in developing interventions like treatments and medical devices for a wide range of cardiovascular diseases. The sheer size and complexity of cardiovascular clinical trials is just one of the factors that make this...

Quality assurance is a critical element of a clinical trial, as it ensures the safety of the participants, as well as the reliability and integrity of the documentation and data, and therefore the validity of your results. But what does it entail, when should it happen, and how can you get it right? We share our insights.

Functional Service Provider (FSP) models can offer biotech and pharma companies more flexibility in the support they get from a CRO while putting them in control. But is it the right choice for your trial? And how can you get the most out of this approach? This blog post explores FSP and its benefits for clinical research.

SCOPE Europe offers an unparalleled opportunity to engage with thought leaders, explore cutting-edge technologies, and network with industry experts. Over the course of two days, attendees will participate in keynote sessions, interactive breakouts, and panel discussions, all while gaining insights into the latest trends in digital and hybrid trials.

Artificial intelligence (AI) promises efficiency, accuracy, and cost savings, but what can it actually deliver when it comes to clinical trials? Whether you’re in the design process of your clinical trial, working on regulatory submissions, recruiting participants, or collecting and analyzing data, there may be AI tools to help.

If you’re looking for the right CRO for your clinical trial, you’re likely considering many factors, including expertise, prior success, budget… but what’s size got to do with it? More than you might think. In this blog post, we look at the benefits of partnering with a smaller CRO.

Used in the right way, decentralization can help put patients at the heart of a clinical trial. But if a fully decentralized or hybrid trial is designed and implemented without considering participants’ perspectives, it can result in gaps in data, low participant retention and delays.